Abstract
THE neurohypophyseal hormone, [Arg8]vasopressin (AVP), like some of its analogues and smaller peptides of related structure, has the capacity to influence memory-related processes through direct action in the central nervous system1–4. These peptides have relatively long-lasting effects on memory consolidation or on retrieval of information1,5. It has been suggested that development of functional tolerance to drug effects involves an adaptive mechanism in the CNS similar to that which occurs during learning and/or memory consolidation6,7. We therefore wished to extend our studies4 of the central actions of the neurohypophyseal hormones to include an investigation of the influence of these peptides on various aspects of functional tolerance to ethanol. One of the most consistently demonstrable effects of the neurohypophyseal peptides with respect to memory is the ability to inhibit the extinction of a conditioned avoidance response1–3,5. We now present evidence that treatment of animals with AVP during and after chronic ethanol administration leads to long-term maintenance of tolerance to the hypothermic and sedative effects of ethanol.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
de Wied, D. et al. in Peptides, Chemistry, Structure, Biology (eds Walter, R. & Meienhofer, J.) 635–643 (Ann Arbor, Ann Arbor, 1975).
de Wied, D., Greven, H. M., Lande, S. & Witter, A. Br. J. Pharm. 45, 118–122 (1972).
Lande, S., Flexner, J. B. & Flexner, L. B. Proc. natn. Acad. Sci. U.S.A. 69, 558–560 (1972).
Walter, R., Hoffman, P. L., Flexner, J. B. & Flexner, L. B. Proc. natn. Acad. Sci. U.S.A. 72, 4180–4184 (1975).
van Wimersma Griedanus, T. B., Bohus, B. & de Wied, D. Prog. Brain Res. 42, 135–141 (1975).
Le Blanc, A. E. & Cappell, H. in Alcohol and Opiates, Neurochemical and Behavioral Mechanisms (ed. Blum, K.) 65–77 (Academic, New York, 1977).
Tabakoff, B. & Ritzmann, R. F. J. Pharmac. exp. Ther. 203, 319–331 (1977).
Ritzmann, R. F. & Tabakoff, B. J. Pharmac. exp. Ther. 199, 158–170 (1976).
Tabakoff, B., Ritzmann, R. F. & Boggan, W. O. J. Neurochem. 24, 1043–1051 (1975).
Hoffman, P., Ritzmann, R. F. & Tabakoff, B. in Currents in Alcoholism Vol. 4 (ed. Sexias, F.) (Grune and Stratton, New York, in the press).
Flexner, J. B., Flexner, L. B., Hoffman, P. L. & Walter, R. Brain Res. 134, 139–144 (1977).
Walter, R. & Simmons, W. H. in Neurohypophysis (eds Moses, A. M. & Share, L.) 167–188 (Karger, Florida, 1976).
Van Ree, J. M. & de Wied, D. Life Sci. 19, 1331–1340 (1976).
Hoffman, P. L., Rainbow, T. C. & Flexner, J. B. (in preparation).
Walter, R. & Havran, R. T. Experientia 27, 645–646 (1971).
Tabakoff, B., Hoffman, P. L. & Ritzmann, R. F. (in preparation).
Beard, J. D. & Knott, D. H. in The Biology of Alcoholism Vol. 1, (eds. Kissin, B. & Begleiter, H.) 353–376 (Plenum, New York, 1971).
Marquis, C., Marchetti, J., Burlet, B. & Boulange, M. C.r. hebd. Soc. Biol., Paris 169, 154–161 (1975).
Sereny, G., Rapoport, A. & Hudson, H. Metabolism 15, 896–904 (1966).
Nikander, P. & Pekkanen, L. Psychopharmacology, 51, 219–224 (1977).
Linkola, J., Fyrquist, F. & Forsander, O. Acta physiol. scand. 101, 126–128 (1977).
J. biol. Chem. 250, 3215 (1975).
The Pharmacopoeia of the United States 17th revision, 750 (Mack, Eastern, Philadelphia, 1965).
Munsick, R. A., Sawyer, W. H. & van Dyke, H. B. Endocrinology 66, 860 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
HOFFMAN, P., RITZMANN, R., WALTER, R. et al. Arginine vasopressin maintains ethanol tolerance. Nature 276, 614–616 (1978). https://doi.org/10.1038/276614a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/276614a0
This article is cited by
-
Vasopressin and alcohol: a multifaceted relationship
Psychopharmacology (2018)
-
Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date
CNS Drugs (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.